Clinical Trials Insight: 700027241
Phase of Trial: Phase II
Latest Information Update: 21 May 2008
At a glance
- Drugs Arimoclomol (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Sponsors CytRx Corporation
- 21 May 2008 The trial is now expected to be initiated in the second half of 2008, according to a CytRx media release.
- 02 Oct 2007 New trial record.